$327,127,680
to LEIDOS BIOMEDICAL RESEARCH INC
NCI OPERATIONAL TASK ORDER, FY26-FY27
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds National Cancer Institute operational and research activities under an existing task order that began in August 2025.
NCI research drives cancer detection, treatment, and prevention advances critical to U.S. public health outcomes and biomedical innovation leadership.
Leidos Biomedical Research supports NCI's laboratory, clinical, and administrative infrastructure; this obligation sustains ongoing vendor and subcontractor relationships.
U.S. cancer research competitiveness depends on sustained funding for NCI's world-leading research programs and talent retention against international competition.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-19. Cost: $0.002986.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75N91025F00016_7529_75N91019D00024_7529.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.